As such, it is possible that loss of Adamts12 with subsequent loss of CD200/CD200R fibroblast-macrophage signaling leads to a dysfunctional attenuation of inflammation in response to other stimuli, i.e., in infection and autoimmune disease, but not fibrosis. Here, CD200 is linked to autoimmune disease.